Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms
- PMID: 7524038
- PMCID: PMC331952
- DOI: 10.1093/nar/22.20.4307
Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms
Abstract
Phosphodiester and phosphorothioate oligonucleotides in alpha and beta configurations directed against the initiation codon region of the HIV-1 rev gene were evaluated for their ability to inhibit HIV-1 replication in acutely and chronically infected human CEM cells. Encapsulation in antibody-targeted liposomes (immunoliposomes) permitted intracellular delivery and distinction between oligonucleotide-mediated inhibition of viral entry and intracellular effects on viral RNA. Our results are consistent with four mechanisms of antiviral activity for these antisense oligonucleotides: (i) interference with virus-mediated cell fusion by free but not liposome-encapsulated phosphorothioate oligonucleotides of any sequence; (ii) interference with reverse transcription in a sequence non-specific manner by phosphorothioate oligonucleotides in alpha and beta configurations; (iii) interference with viral reverse transcription in a sequence-specific and RNase-H-independent manner by alpha and beta phosphodiester oligonucleotides; (iv) interference with viral mRNA in a sequence-specific and RNase-H-dependent manner by beta-phosphorothioate oligonucleotides.
Similar articles
-
Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.Antisense Res Dev. 1993 Winter;3(4):323-38. doi: 10.1089/ard.1993.3.323. Antisense Res Dev. 1993. PMID: 8155974
-
Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.Biochem Biophys Res Commun. 1996 Nov 12;228(2):623-31. doi: 10.1006/bbrc.1996.1707. Biochem Biophys Res Commun. 1996. PMID: 8920960
-
Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.Biochem Biophys Res Commun. 1997 Apr 28;233(3):742-7. doi: 10.1006/bbrc.1997.6536. Biochem Biophys Res Commun. 1997. PMID: 9168925
-
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?Science. 1993 Aug 20;261(5124):1004-12. doi: 10.1126/science.8351515. Science. 1993. PMID: 8351515 Review.
-
Oligonucleotides as inhibitors of human immunodeficiency virus.Curr Opin Mol Ther. 1999 Jun;1(3):323-31. Curr Opin Mol Ther. 1999. PMID: 11713797 Review.
Cited by
-
Antisense inhibition of virus infections.Adv Pharmacol. 1997;40:437-83. doi: 10.1016/s1054-3589(08)60147-7. Adv Pharmacol. 1997. PMID: 9217933 Free PMC article. Review.
-
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.Acta Naturae. 2009 Jul;1(2):44-60. Acta Naturae. 2009. PMID: 22649602 Free PMC article.
-
Innovations in oligonucleotide drug delivery.J Pharm Sci. 2003 Aug;92(8):1559-73. doi: 10.1002/jps.10399. J Pharm Sci. 2003. PMID: 12884243 Free PMC article. Review.
-
Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.Biophys J. 2005 Oct;89(4):2286-95. doi: 10.1529/biophysj.104.054080. Epub 2005 Jul 29. Biophys J. 2005. PMID: 16055530 Free PMC article.
-
Antisense delivery using protamine-oligonucleotide particles.Nucleic Acids Res. 2000 May 15;28(10):E45. doi: 10.1093/nar/28.10.e45. Nucleic Acids Res. 2000. PMID: 10773093 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources